Journal Mobile Options
Table of Contents
Vol. 29, No. 4, 2010
Issue release date: May 2010
Dement Geriatr Cogn Disord 2010;29:287–293
(DOI:10.1159/000295115)

Insular Hypoperfusion Correlates with the Severity of Delusions in Individuals with Alzheimer’s Disease

Matsuoka T. · Narumoto J. · Shibata K. · Okamura A. · Nakamura K. · Okuyama C. · Nishimura T. · Fukui K.
Departments of aPsychiatry and bRadiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: The aim of this study was to identify the brain regions associated with the severity of delusions in individuals with Alzheimer’s disease (AD) using single-photon emission computed tomography. Methods: Thirty-five AD patients participated in this study. Multiple regression analysis was performed to identify a linear correlation between the delusion subscale score of the Neuropsychiatric Inventory (NPI) and regional cerebral blood flow (rCBF) in AD patients with delusions (n = 14). In addition, rCBF in patients with (n = 14) and without delusions (n = 21) was compared using a 2-sample t test. Results: The delusion subscale score of the NPI was negatively correlated with rCBF in the right anterior insula (uncorrected p < 0.01 at the voxel level and corrected p < 0.05 at the cluster level). Compared to patients without delusions, however, rCBF in the right anterior insula was not significantly decreased in patients with delusions. Conclusion: We suggest that right anterior insular dysfunction may exacerbate delusions, although it is not responsible for the onset of delusions.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Wragg RE, Jeste DV: Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 1989;146:577–587.
  2. Matsumoto N, Ikeda M, Fukuhara R, Shinagawa S, Ishikawa T, Mori T, Toyota Y, Matsumoto T, Adachi H, Hirono N, Tanabe H: Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord 2007;23:219–224.
  3. Steele C, Rovner B, Chase GA, Folstein M: Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry 1990;147:1049–1051.
  4. Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med 2006;355:1525–1538.
  5. Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, Blow FC: Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 2007;164:1568–1576.
  6. Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R: The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009;8:151–157.
  7. Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R: SPECT findings on psychosis in Alzheimer’s disease. Am J Psychiatry 1995;152:1470–1475.
  8. Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL: Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2000;69:167–171.
  9. Lopez OL, Smith G, Becker JT, Meltzer CC, De Kosky ST: The psychotic phenomenon in probable Alzheimer’s disease: a positron emission tomography study. J Neuropsychiatry Clin Neurosci 2001;13:50–55.
  10. Staff RT, Shanks MF, Macintosh L, Pestell SJ, Gemmell HG, Venneri A: Delusions in Alzheimer’s disease: SPET evidence of right hemispheric dysfunction. Cortex 1999;35:549–560.
  11. Nakano S, Yamashita F, Matsuda H, Kodama C, Yamada T: Relationship between delusions and regional cerebral blood flow in Alzheimer’s disease. Dement Geriatr Cogn Disord 2006;21:16–21.
  12. Bruen PD, McGeown WJ, Shanks MF, Venneri A: Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 2008;131:2455–2463.
  13. Sultzer DL, Brown CV, Mandelkern MA, Mahler ME, Mendez MF, Chen ST, Cummings JL: Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer’s disease. Am J Psychiatry 2003;160:341–349.
  14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  15. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  16. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  17. Fukuhara R, Ikeda M, Nebu A, Kikuchi T, Maki N, Hokoishi K, Shigenobu K, Komori K, Tanabe H: Alteration of rCBF in Alzheimer’s disease patients with delusions of theft. Neuroreport 2001;12:2473–2476.
  18. Moran EK, Becker JA, Satlin A, Lyoo IK, Fischman AJ, Johnson KA: Psychosis of Alzheimer’s disease: gender differences in regional perfusion. Neurobiol Aging 2008;29:1218–1225.
  19. Crespo-Facorro B, Kim J, Andreasen NC, O’Leary DS, Bockholt HJ, Magnotta V: Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 2000;46:35–43.
  20. Mesulam MM, Mufson EJ: Insula of the old world monkey. III. Efferent cortical output and comments on function. J Comp Neurol 1982;212:38–52.
  21. Craig AD: How do you feel – now? The anterior insula and human awareness. Nat Rev Neurosci 2009;10:59–70.
  22. Royall DR, Gao JH, Kellogg DL Jr: Insular Alzheimer’s disease pathology as a cause of ‘age-related’ autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses 2006;67:747–758.
  23. Royall D, Gao JH, Zhao X, Polk MJ, Kellogg D: Asymmetric insular function predicts positional blood pressure in nondemented elderly. J Neuropsychiatry Clin Neurosci 2009;21:173–180.
  24. Braak H, Braak E, Bohl J, Lang W: Alzheimer’s disease: amyloid plaques in the cerebellum. J Neurol Sci 1989;93:277–287.
  25. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y: Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol 1989;77:314–319.
  26. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E: Reduction of cerebellar glucose metabolism in advanced Alzheimer’s disease. J Nucl Med 1997;38:925–928.
  27. Minoshima S, Frey KA, Foster NL, Kuhl DE: Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995;19:541–547.
  28. Akiyama H, Harrop R, McGeer PL, Peppard R, McGeer EG: Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer’s disease. Neurology 1989;39:541–548.
  29. Ramnani N: The primate cortico-cerebellar system: anatomy and function. Nat Rev Neurosci 2006;7:511–522.
  30. Andreasen NC, Pierson R: The role of the cerebellum in schizophrenia. Biol Psychiatry 2008;64:81–88.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50